Douwe H. Biesma

Santeon (Netherlands), St. Antonius Ziekenhuis

Papers

5

Total Citations

159

H-Index

5

About

Douwe H. Biesma has made significant contributions to the field of urologic oncology, with a primary focus on improving the accuracy of prostate cancer staging and risk stratification. His research centers on the development and validation of predictive nomograms that integrate advanced imaging, particularly multiparametric magnetic resonance imaging (mpMRI), to refine clinical decision-making. Biesma’s most impactful work includes the creation of a novel nomogram to predict side-specific extraprostatic extension in patients undergoing radical prostatectomy, which has been cited 61 times. He has also demonstrated that mpMRI should be preferred over digital rectal examination for local staging and disease risk classification, a finding with 57 citations. Additionally, Biesma has externally validated established nomograms from Memorial Sloan Kettering Cancer Centre and Briganti, showing that incorporating mpMRI-based clinical stage improves the prediction of lymph node involvement. His work has been instrumental in advancing personalized surgical planning and reducing unnecessary interventions. With a cumulative citation count exceeding 150 across his top papers, Biesma is recognized as a key figure in the integration of imaging into prostate cancer management.

Research Focus

Key Achievements

5
H-Index
5
Papers
159
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy
61 citations · 2020
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Santeon (Netherlands), St. Antonius Ziekenhuis

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago